Mr. Kunal Gandhi purchased 14,176 shares of Lyka Labs Limited via an open market transaction, increasing his holding from 3,500,162 to 3,514,338 shares.
A pharmaceutical manufacturer engaged in developing, producing, and marketing finished dosage formulations across multiple therapeutic areas. Incorporated in 1976, the company focuses on quality manufacturing and distribution of pharmaceutical products to meet domestic healthcare needs. Lyka Labs operates as a vertically integrated player in India's pharmaceutical sector, serving patients and healthcare providers through its diversified portfolio of generic and branded medications across various treatment segments.
Get the next move the moment it happens.
Follow the investors and Lyka Labs Limited on WhaleWatch, alongside 300+ top investors, funds and FPIs. The newest moves are waiting for you inside.
